AstraZeneca Pharma India Ltd. — Board/Management Information 2023

Oct 30, 2023

==> picture [524 x 91] intentionally omitted <==

October 30, 2023

The Manager - Listing National Stock Exchange of India Ltd. Exchange plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051

The Manager - Listing BSE Limited Corporate Relationship Dept., 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 400001

Dear Sirs,

Sub: Meeting of the Board of Directors of the Company to be held on Thursday, November 9, 2023 – Ref: Scrip Code BSE: 506820, NSE: ASTRAZEN

This is to inform that the Meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Thursday, November 9, 2023 inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.

We would also like to inform you that the ‘Trading Window’ remains closed for all Designated Persons, from September 16, 2023 to November 11, 2023 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

We request you to please take the same on record.

Thanking you, Yours faithfully,

For AstraZeneca Pharma India Limited

MANASA Digitally signed by MANASA RAMA RAMA Date: 2023.10.30 16:13:26 +05'30' Manasa. R Company Secretary

==> picture [452 x 64] intentionally omitted <==